Results · Apr-Jun 2026
Divi's Laboratories Q1 FY27 results
BlockbusterBlockbuster: sales up 20% or more & profit up 30% or more on the same quarter last year, with a wider operating margin.
Sales grew 28% to ₹3,080 crore from ₹2,410 crore in Apr-Jun 2025.
Operating profit grew 72% to ₹1,255 crore, an operating margin of 40.7% (up 10.5 points from a year ago).
Net profit grew 66% to ₹902 crore from ₹545 crore in Apr-Jun 2025.
Against Jan-Mar 2026: sales +9%, net profit +20%.
Apr-Jun 2026 vs a year ago
| ₹ crore | Apr-Jun 2026 | Apr-Jun 2025 | Change |
|---|---|---|---|
| Sales | 3,080 | 2,410 | +28% |
| Operating profit (EBITDA) | 1,255 | 729.0 | +72% |
| Operating margin | 40.7% | 30.2% | +10.5 pts |
| Net profit | 902.0 | 545.0 | +66% |
Consolidated figures. Margins & ratios change in percentage points (pts).
The last 7 quarters
From the company's results filed on BSE (Consolidated). Business numbers only. Education & analysis, not investment advice or a recommendation.